Sue Stephens

4.6k total citations · 1 hit paper
36 papers, 3.4k citations indexed

About

Sue Stephens is a scholar working on Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sue Stephens has authored 36 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 9 papers in Epidemiology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sue Stephens's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Inflammatory Bowel Disease (7 papers) and Immune Response and Inflammation (6 papers). Sue Stephens is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Inflammatory Bowel Disease (7 papers) and Immune Response and Inflammation (6 papers). Sue Stephens collaborates with scholars based in United Kingdom, United States and Germany. Sue Stephens's co-authors include Stephen J. Nicholls, Thomas T. MacDonald, Christian Braegger, Simon Murch, Roly Foulkes, Andrew Nesbitt, Niti Goel, Derek Brown, Tim Bourne and Mark Bodmer and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Blood.

In The Last Decade

Sue Stephens

36 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1992 578 citations Christian Braegger, Stephen J. Nicholls et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sue Stephens	1.3k	1.0k	899	577	445	36	3.4k
LA Aarden	1.7k 1.3×	973 0.9×	215 0.2×	619 1.1×	371 0.8×	36	3.9k
David J. Shealy	2.3k 1.8×	964 0.9×	1.3k 1.5×	1.1k 1.9×	600 1.3×	40	5.1k
Jonas Mudter	1.4k 1.1×	761 0.7×	1.4k 1.6×	550 1.0×	840 1.9×	71	3.7k
Luisa Imberti	2.2k 1.7×	642 0.6×	583 0.6×	596 1.0×	144 0.3×	156	3.8k
Minoru Nakamura	1.2k 1.0×	1.5k 1.5×	376 0.4×	663 1.1×	780 1.8×	130	3.9k
Lionel Fry	1.8k 1.4×	910 0.9×	353 0.4×	421 0.7×	628 1.4×	114	4.9k
Jeffrey Siegel	2.1k 1.6×	1.8k 1.8×	668 0.7×	960 1.7×	1.1k 2.6×	41	6.1k
Zoltán Lászik	1.0k 0.8×	759 0.7×	324 0.4×	998 1.7×	493 1.1×	87	3.9k
Liliane Schandené	2.0k 1.5×	681 0.7×	302 0.3×	443 0.8×	995 2.2×	96	4.2k
Bruce Yacyshyn	654 0.5×	1.3k 1.2×	1.8k 2.0×	857 1.5×	948 2.1×	78	3.5k

Countries citing papers authored by Sue Stephens

Since Specialization

Citations

This map shows the geographic impact of Sue Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Stephens more than expected).

Fields of papers citing papers by Sue Stephens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Stephens. The network helps show where Sue Stephens may publish in the future.

Co-authorship network of co-authors of Sue Stephens

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Stephens. A scholar is included among the top collaborators of Sue Stephens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Stephens. Sue Stephens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stephens, Sue, Marc Botteman, M. Cifaldi, & Ben A. van Hout. (2015). Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease. BMJ Open. 5(6). e006560–e006560. 10 indexed citations

Wakefield, Ian, Sue Stephens, Roly Foulkes, Andrew Nesbitt, & Tim Bourne. (2011). The Use of Surrogate Antibodies to Evaluate the Developmental and Reproductive Toxicity Potential of an Anti-TNFα PEGylated Fab′ Monoclonal Antibody. Toxicological Sciences. 122(1). 170–176. 24 indexed citations

Goel, Niti & Sue Stephens. (2010). Certolizumab Pegol. mAbs. 2(2). 137–147. 138 indexed citations

Nesbitt, Andrew, Gianluca Fossati, Marianne Bergin, et al.. (2007). Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents. Inflammatory Bowel Diseases. 13(11). 1323–1332. 372 indexed citations

Thom, Michelle, Jayne C. Hope, Martin McAulay, et al.. (2006). The effect of tuberculin testing on the development of cell-mediated immune responses during Mycobacterium bovis infection. Veterinary Immunology and Immunopathology. 114(1-2). 25–36. 34 indexed citations

DiJoseph, John F., Andrew G. Popplewell, Simon Tickle, et al.. (2004). Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22. Cancer Immunology Immunotherapy. 54(1). 11–24. 55 indexed citations

McGuire, William, Umberto D’Alessandro, Sue Stephens, et al.. (1998). Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(1). 50–53. 23 indexed citations

Owens, Raymond J., Ramaswamy Ganesh, Andrew Nesbitt, et al.. (1997). The in vivo and in vitro characterisation of an engineered human antibody to E-selectin. Immunotechnology. 3(2). 107–116. 9 indexed citations

Evans, R.C., Lane L. Clarke, Patricia K. Heath, et al.. (1997). Treatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571. Alimentary Pharmacology & Therapeutics. 11(6). 1031–1035. 101 indexed citations

10.

Dhainaut, Jean-François, Jean‐Louis Vincent, Christian Richard, et al.. (1995). CDP571, a humanized antibody to human tumor necrosis factor-alpha. Critical Care Medicine. 23(9). 1461–1469. 96 indexed citations

11.

Suitters, Amanda, Roly Foulkes, Steven M. Opal, et al.. (1994). Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.. The Journal of Experimental Medicine. 179(3). 849–856. 52 indexed citations

12.

Dickinson, Anne M., Lisbet Sviland, Graham Jackson, et al.. (1994). Monoclonal anti-TNF-α suppresses graft vs host disease reactions in an in vitro human skin model. Cytokine. 6(2). 141–146. 4 indexed citations

13.

Fisher, Charles J., Steven M. Opal, Jean-François Dhainaut, et al.. (1993). Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Critical Care Medicine. 21(3). 318–327. 325 indexed citations

14.

Probert, Lesley, Paola Corbella, Evangelia Patsavoudi, et al.. (1993). Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes.. The Journal of Immunology. 151(4). 1894–1906. 75 indexed citations

15.

Charpentier, Bernard, C Hiesse, Olivier Lantz, et al.. (1992). EVIDENCE THAT ANTIHUMAN TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODY PREVENTS OKT3-INDUCED ACUTE SYNDROME. Transplantation. 54(6). 997–1001. 61 indexed citations

16.

Braegger, Christian, Stephen J. Nicholls, Simon Murch, Thomas T. MacDonald, & Sue Stephens. (1992). Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. The Lancet. 339(8785). 89–91. 578 indexed citations breakdown →

17.

Noronha, Irene L., Maria Eberlein-Gonska, B. Hartley, et al.. (1992). IN SITU EXPRESSION OF TUMOR NECROSIS FACTOR-ALPHA, INTERFERON-GAMMA, AND INTERLEUKIN-2 RECEPTORS IN RENAL ALLOGRAFT BIOPSIES. Transplantation. 54(6). 1017–1024. 92 indexed citations

18.

Seu, Philip, David K. Imagawa, Kim M. Olthoff, et al.. (1991). Monoclonal anti-tumor necrosis factor-α antibody treatment of rat cardiac allografts: Synergism with low-dose cyclosporine and immunohistological studies. Journal of Surgical Research. 50(5). 520–528. 9 indexed citations

19.

Imagawa, David K., J. Michael Millis, Philip Seu, et al.. (1991). THE ROLE OF TUMOR NECROSIS FACTOR IN ALLOGRAFT REJECTION. Transplantation. 51(1). 57–62. 106 indexed citations

20.

Exley, Andrew, J. Cohen, Wim A. Buurman, et al.. (1990). Monoclonal antibody to TN F in severe septic shock. The Lancet. 335(8700). 1275–1277. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact